Medicamen Organics has disclosed a valuation report dated March 12, 2026, issued by M/s Jhamb & Associates, Company Secretaries, in connection with its Extra-Ordinary General Meeting (EGM). The report, prepared by a Registered Valuer in accordance with the SEBI (ICDR) Regulations, 2018, is now available for shareholder review. This disclosure follows previous intimations dated March 17, 2026, and March 27, 2026, regarding the submission of the EGM notice and a subsequent corrigendum.

The EGM is scheduled for May 23, 2026, to seek shareholder approval for various matters specified in the notice. The valuation report provides the necessary financial assessment required for the agenda items being presented. The company has made the document accessible to ensure transparency and informed decision-making by its shareholders.

Key Details of the Disclosure

Shareholders of Medicamen Organics can access the full valuation report on the company’s official website under the corporate announcements section for the financial year 2026-27. The filing was submitted to the National Stock Exchange of India Limited on May 23, 2026, by Divya Sharma, Company Secretary & Compliance Officer.

Medicamen Organics , a pharmaceutical company, has announced a significant strategic move by entering the beauty and personal care sector. This expansion marks a diversification of the company's business portfolio, potentially opening up new revenue streams and market opportunities.

Strategic Expansion

The company's decision to venture into the beauty and personal care industry represents a notable shift from its traditional focus on pharmaceutical products. This move could be seen as a response to the growing consumer demand for personal care items and the lucrative nature of the beauty industry.

Details Awaited

While the announcement has been made public, specific details about the new product line or the scale of this venture remain undisclosed. Investors and industry observers will likely be keen to learn more about:

• The types of beauty and personal care products Medicamen Organics plans to introduce
• The target market for these new offerings
• The expected timeline for the launch of these products
• Any partnerships or collaborations that might be involved in this new venture

Potential Impact

This strategic entry into a new sector could have several implications for Medicamen Organics:

1. Diversification: By expanding into beauty and personal care, the company is diversifying its revenue sources, which could potentially provide more stability and growth opportunities.

2. Market Expansion: This move allows Medicamen Organics to tap into the vast and growing beauty and personal care market, possibly reaching new customer segments.

3. Synergies: There might be potential synergies between the company's pharmaceutical expertise and the development of personal care products, particularly in areas like skincare.

4. Competition: The beauty and personal care sector is highly competitive, with established players and numerous brands. Medicamen Organics will need to carve out its niche in this crowded market.

As more information becomes available, stakeholders will be better positioned to assess the potential impact of this strategic move on Medicamen Organics' future growth and market position. The company's ability to leverage its existing strengths in the pharmaceutical sector while adapting to the unique challenges of the beauty and personal care industry will be crucial to the success of this new venture.